Autism Information and Resources
Due to the amount of content and information about Autism Spectrum Disorders this page has been categorized for your convenience:
The purpose of this statement is to convey a consensus amongst Arizona pediatricians regarding best approaches to the screening, referral, diagnosis, and treatment of children with Autism Spectrum Disorders (ASD) in Arizona.
This study evaluates the validity of proposed DSM-5 criteria for Autism Spectrum Disorder.
In this article developmental model which conceptualizes the child's functional emotional developmental capacities, individual differences in sensory processing and modulation, motor planning and sequencing, as well as child/caregiver and family interaction patterns are discussed.
This PowerPoint presentation by Dr. Robin Blitz defines ASD and its diagnosis criteria.
This PowerPoint presentation by Dr. Robin Blitz provides an overview of ASD diagnostic screening tools and evaluation techniques.
This article discusses the history and genetics of ASD.
This commentary identifies three areas for improvement and expansion to the AAP's Guidelines for Early Identification, Screening and Clinical Management of Children with ASD.
This report addresses background information, including definition, history, epidemiology, diagnostic criteria, early signs, neuropathologic aspects, and etiologic possibilities in autism spectrum disorders.
The M-CHAT is designed to screen for Autism Spectrum Disorders in toddlers (i.e., over the age of 12 months, and ideally over the age of 18 months). A parent can complete the items independently.
This practice parameter reviews the available empirical evidence and gives specific recommendations for the identification of children with autism.
This article characterizes the deficits of a child who has Autism and describes the role of linguistic and social development observation and strategies for surveillance and screening of young children.
The goal of this policy statement is to help the pediatrician recognize the early symptoms of autism and participate in its diagnosis and management. This statement and the accompanying technical report will serve to familiarize the pediatrician withcurrently accepted criteria defining the spectrum of autism, strategies used in making a diagnosis, and conventional and alternative interventions.
This technical report serves to complement and expand on the information in the accompanying policy statement to increase the pediatrician's fund of knowledge and comfort level in caring for children with autism.
This PowerPoint presentation by Dr. Robin Blitz provides an overview of treatment options for children diagnosed with ASD.
Autism Part 3: Psychopharmacology of Autism: McDougle, CJ, Posey, D. Genetics of Childhood Disorders: XLIV. J Am Acad Child Adoles Psychiatry. 2002; 41 (11): 1380-1383.
This presentation from the National Research Council, Committee on Educational Interventions for Children with Autism identifies educational techniques and approaches to use when educating children diagnosed with ASD.
A tool kit from Autism Speaks to assist families in getting the critical information they need in the first 100 days after an autism diagnosis.
To assist pediatricians in educating families and guiding them toward empirically supported interventions for their children, this report reviews the educational strategies and associated therapies that are the primary treatments for children with autism spectrum disorders.
The Picture Exchange Communication System (PECS) was developed in 1987 by Lori Frost, MS, CCC/SLP and Dr. Andrew Bondy. PECS is primarily used with individuals who are nonverbal or use speech with limited effectiveness to assist them in acquiring functional communication skills.
The purpose of this statement from the AAP is to assist the pediatrician in assuming a proactive role on the multidisciplinary team providing early intervention services for a child diagnosed with ASD.
This guide from the Arizona Autism Coalition provides information for determining eligibilty and coverage under Steven's Law.
Recent studies suggest that familial autoimmunity plays a part in the pathogenesis of ASDs. In this study association between family history of autoimmune diseases (ADs) and ASDs/infantile autism is investigated.
The causes of autism are unknown; however, evidence increasingly suggests that a complex interplay among environmental stressors, genetic mutations, and other biological factors likely plays a significant role in the development and/or progression of autism spectrum disorder. Oppertunities for further research are discussed.
This article from the National Institute of Mental Health (NIMH) discusses the origin of ASD including its relationship to Asperger Syndrome and Pervasive Developmental Disorders.
The purpose of this report is to present data from a population-based, multisite surveillance network were used to determine the prevalence of children aged 8 years with autism spectrum disorder (ASD) in six areas of the United States and to describe the characteristics of these children.
This report presents results for 2006 from 11 ADDM Network sites and describes updated ASD prevalence overall and by race or ethnicity, sex, level of cognitive functioning, ASD subtype, and multiple associated characteristics.
This article discusses the early origins and history of Autism.
This review article explores the genentics of Autism and offers suggestions for future research.
Parents PACK: Proccessing, Assessing, and Communicating Knowledge about Vaccines
This website developed by the Vaccine Education Center at the Children's Hospital of Philadelphia to establish a place to get up-to-date information about vaccines.
The CDC: www.cdc.gov/vaccines
This website from the CDC provides information and quidelines about immunizations in the United States.
This PowerPoint presentation by Dr. Robin Blitz discusses complementary and alternative medicine approaches in the treatment and management of ASD.